Dermatology Made Easy is based on the most popular topics from DermNet NZ's vast array of material. The book combines the essential focus of the ‘Made Easy’ book series with the authority and knowledge base of DermNet NZ's unparalleled resources.
Author: Vanessa Ngan, Staff Writer, 2012.
Bisoctrizole is a hybrid sun-blocking agent that is used in sunscreen products. It has both chemical absorbing and physical blocking properties and is able to protect against the full spectrum of ultraviolet rays. It both absorbs, reflects and scatters UV rays in the UVA and UVB range. It also has the added advantage of being photostable so does not degrade when exposed to sunlight. When combined with the UVB chemical absorbing sunscreen, octinoxate, it makes the product even more photostable. It also appears to be compatible with most other UVB and UVA sunscreen agents.
Bisoctrizole is approved for use in Europe and other parts of the world. It is marketed under the brand names Tinosorb M. It is currently not approved by the FDA so is not available in the USA.
Because bisoctrizole is relatively new to the sunscreen market there are few reports or studies available documenting its adverse effects and long term use. Studies to date have shown it to have a good safety profile. It is not significantly absorbed into the skin and rarely caused skin irritation. Unlike some other organic sunscreen agents, in vitro studies show that bisoctrizole does not appear to have hormonal effects. Further long-term human safety studies are required.
CAS number: 103597-45-1
Cross reactions: unknown
See the DermNet NZ bookstore
© 2018 DermNet New Zealand Trust.
DermNet NZ does not provide an online consultation service. If you have any concerns with your skin or its treatment, see a dermatologist for advice.